Skip to content

Prohibited pharmaceutical

Carbromal (INN)

CAS 77-65-6
5

Safety score · 0–100

Avoid

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

A withdrawn brominated sedative drug prohibited from EU cosmetics under Annex II. Has no place in personal care products due to systemic toxicity and lack of cosmetic function.

Skin benefits

  • Historical pharmaceutical sedative-hypnotic
  • No cosmetic benefit recognized

Known concerns

  • EU prohibits in cosmetics (Annex II)
  • Bromine-containing sedative with toxicity risks
  • Withdrawn from medical use due to safety profile
  • Chronic exposure causes bromism and neurological harm

References

EU

EU CosIng database

European Commission cosmetic ingredient registry: regulatory status, restrictions, authorised functions.

Related prohibited pharmaceuticals

5
5,5-Diphenyl-4-imidazolidone (Doxenitoin (INN))
Prohibited pharmaceutical
 5
Metheptazine (INN) and its salts
Prohibited pharmaceutical
 3
Phenylpropanolamine hydrochloride [USAN:INN:BAN]
Prohibited pharmaceutical
 8
Furfuryltrimethyl ammonium salts, e.g. furtrethonium iodide (INN)
Prohibited pharmaceutical
 12
bambuterol
Prohibited pharmaceutical
 12
norfenefrine
Prohibited pharmaceutical

Check your shelf

Find Carbromal (INN) in your products.

Scan any cosmetic product with LuxSense to see if it contains Carbromal (INN) and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve, so always read the physical product label and consult a healthcare professional for personal concerns.